Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
FULC: 60% | FDA Lifts Clinical Hold on Fulcrum Therapeutics' FTX-6058 for Sickle Cell Disease
PMN: 52% | ProMIS Neurosciences Announces $20.4M Private Placement Financing At $1.88/Unit
FN: 20% | Fabrinet Q4 EPS $1.86 Beats $1.80 Estimate, Sales $655.87M Beat $641.41M Estimate